129 related articles for article (PubMed ID: 37516212)
21. Beta toxin is essential for the intestinal virulence of Clostridium perfringens type C disease isolate CN3685 in a rabbit ileal loop model.
Sayeed S; Uzal FA; Fisher DJ; Saputo J; Vidal JE; Chen Y; Gupta P; Rood JI; McClane BA
Mol Microbiol; 2008 Jan; 67(1):15-30. PubMed ID: 18078439
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
Saleh N; Fathalla SI; Nabil R; Mosaad AA
Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285
[TBL] [Abstract][Full Text] [Related]
23. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
[TBL] [Abstract][Full Text] [Related]
24. Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine.
Salvarani FM; Conceição FR; Cunha CE; Moreira GM; Pires PS; Silva RO; Alves GG; Lobato FC
Vaccine; 2013 Aug; 31(38):4152-5. PubMed ID: 23845812
[TBL] [Abstract][Full Text] [Related]
25. Immunization with recombinant alpha toxin partially protects broiler chicks against experimental challenge with Clostridium perfringens.
Cooper KK; Trinh HT; Songer JG
Vet Microbiol; 2009 Jan; 133(1-2):92-7. PubMed ID: 18635321
[TBL] [Abstract][Full Text] [Related]
26. Cattle and goats' humoral response to vaccination with Clostridium perfringens type D purified epsilon toxoids.
Oliveira RC; de Oliveira Júnior CA; Alves GG; Assis RA; Silva ROS; de Sousa Xavier MA; Lobato FCF
Anaerobe; 2021 Dec; 72():102465. PubMed ID: 34662696
[TBL] [Abstract][Full Text] [Related]
27. Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis.
Kulkarni RR; Parreira VR; Sharif S; Prescott JF
Clin Vaccine Immunol; 2007 Sep; 14(9):1070-7. PubMed ID: 17634510
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of recombinant bivalent fusion protein r-Cpib for immunotherapy against Clostridium perfringens beta and iota toxemia.
Das S; Majumder S; Kingston JJ; Batra HV
Mol Immunol; 2016 Feb; 70():140-8. PubMed ID: 26774054
[TBL] [Abstract][Full Text] [Related]
29. Prevalence, Genotypic and Phenotypic Characterization and Antibiotic Resistance Profile of
Mohiuddin M; Iqbal Z; Siddique A; Liao S; Salamat MKF; Qi N; Din AM; Sun M
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33066416
[No Abstract] [Full Text] [Related]
30. A non-toxic recombinant protein rSUMO-CPBm4 as a potential vaccine candidate against Clostridium perfringens type C beta enterotoxemia.
Goa Y; Du JG; Jirapattharasate C; Galon E; Ji SW; Ran ZG; Xia YQ
Trop Biomed; 2023 Dec; 40(4):400-405. PubMed ID: 38308826
[TBL] [Abstract][Full Text] [Related]
31. In vitro characterization and immunogenicity of chitosan nanoparticles loaded with native and inactivated extracellular proteins from a field strain of Clostridium perfringens associated with necrotic enteritis.
Akerele G; Ramadan N; Renu S; Renukaradhya GJ; Shanmugasundaram R; Selvaraj RK
Vet Immunol Immunopathol; 2020 Jun; 224():110059. PubMed ID: 32408182
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of Clostridium perfringens epsilon toxin recombinant bacterin in rabbit and ruminants.
Ferreira MRA; Dos Santos FD; da Cunha CEP; Moreira C; Donassolo RA; Magalhães CG; Belo Reis AS; Oliveira CMC; Barbosa JD; Leite FPL; Salvarani FM; Conceição FR
Vaccine; 2018 Nov; 36(50):7589-7592. PubMed ID: 30389190
[No Abstract] [Full Text] [Related]
33. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for
Ding G; Bai J; Feng B; Wang L; Qiao X; Zhou H; Jiang Y; Cui W; Tang L; Li Y; Xu Y
Virulence; 2019 Dec; 10(1):754-767. PubMed ID: 31429624
[No Abstract] [Full Text] [Related]
34. Salmonella-vectored vaccine delivering three Clostridium perfringens antigens protects poultry against necrotic enteritis.
Wilde S; Jiang Y; Tafoya AM; Horsman J; Yousif M; Vazquez LA; Roland KL
PLoS One; 2019; 14(2):e0197721. PubMed ID: 30753181
[TBL] [Abstract][Full Text] [Related]
35. In silico design and in vitro analysis of a recombinant trivalent fusion protein candidate vaccine targeting virulence factor of Clostridium perfringens.
Katalani C; Nematzadeh G; Ahmadian G; Amani J; Kiani G; Ehsani P
Int J Biol Macromol; 2020 Mar; 146():1015-1023. PubMed ID: 31726124
[TBL] [Abstract][Full Text] [Related]
36. A live oral recombinant Salmonella enterica serovar typhimurium vaccine expressing Clostridium perfringens antigens confers protection against necrotic enteritis in broiler chickens.
Kulkarni RR; Parreira VR; Jiang YF; Prescott JF
Clin Vaccine Immunol; 2010 Feb; 17(2):205-14. PubMed ID: 20007363
[TBL] [Abstract][Full Text] [Related]
37. Application of an Endothelial Cell Culture Assay for the Detection of Neutralizing Anti-Clostridium Perfringens Beta-Toxin Antibodies in a Porcine Vaccination Trial.
Richard OK; Springer S; Finzel J; Theuß T; Wyder M; Vidondo B; Posthaus H
Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30991691
[TBL] [Abstract][Full Text] [Related]
38. Vaccination schedules to raise antibody concentrations against epsilon-toxin of Clostridium perfringens in ewes and their triplet lambs.
de la Rosa C; Hogue DE; Thonney ML
J Anim Sci; 1997 Sep; 75(9):2328-34. PubMed ID: 9303449
[TBL] [Abstract][Full Text] [Related]
39. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
[TBL] [Abstract][Full Text] [Related]
40. Novel toxin-based mRNA vaccine against Clostridium perfringens using in silico approaches.
Asadollahi P; Kalani BS
Toxicon; 2024 Feb; 238():107584. PubMed ID: 38185287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
